INVESTIGATION OF THE RELATIONSHIP BETWEEN ALTERED INTRACELLULAR PH AND MULTIDRUG RESISTANCE IN MAMMALIAN-CELLS

被引:73
作者
BOSCOBOINIK, D [1 ]
GUPTA, RS [1 ]
EPAND, RM [1 ]
机构
[1] MCMASTER UNIV,HLTH SCI CTR,DEPT BIOCHEM,1200 MAIN ST,HAMILTON L8N 3Z5,ONTARIO,CANADA
基金
英国医学研究理事会;
关键词
D O I
10.1038/bjc.1990.127
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The intracellular pH of a number of multidrug resistant cell lines was compared with that of their parental lines using the fluorescent probebis-carboxyethylcarboxyfluorescein. In four different cases, cells having 5-fold resistance or more exhibited an intracellular pH which was 0. 10-0. 17 units higher than that of the parental cell line. A CHO cell line, AB, and its 180-fold resistant counterpart, CHRC5, were further investigated with regard to the role of Na+/H+ antiport. The Na+/H+ antiport activity was greater at any intracellular pH for the CHRC5 cells than the AB, cells. To investigate the possible role of higher intracellular pH in multidrug resistance, the effect of several agents which are either known to reverse multidrug resistance or inhibit Na+/H+ antiport activity were examined. Verapamil was found to reverse multidrug resistance but had no effect on intracellular pH while amiloride, which acidities the cytoxol by blocking Na+/H+ antiport activity, did not cause reversal of drug resistance. In contrast to verapamil, treatment of CHRC5 cells with cyclosporin A had a parallel effect on reversal of their drug resistant phenotype and a lowering of their intracellular pH to that of the sensitive cell level. However, cyclosporin was ineffective in either lowering the intracellular pH or reversing drug resistance in DC3F/ADX cells. Therefore, except for the effect of cyclosporin A on the CHRC5 line, the effects of other agents on reversal of multidrug resistance and intracellular pH did not correlate with each other. © Macmillan Press Ltd., 1990.
引用
收藏
页码:568 / 572
页数:5
相关论文
共 20 条
[1]   ISOLATION AND GENETIC-CHARACTERIZATION OF HUMAN KB-CELL LINES RESISTANT TO MULTIPLE-DRUGS [J].
AKIYAMA, SI ;
FOJO, A ;
HANOVER, JA ;
PASTAN, I ;
GOTTESMAN, MM .
SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (02) :117-126
[2]   PLEIOTROPIC PHENOTYPE OF COLCHICINE-RESISTANT CHO CELLS - CROSS-RESISTANCE AND COLLATERAL SENSITIVITY [J].
BECHHANSEN, NT ;
TILL, JE ;
LING, V .
JOURNAL OF CELLULAR PHYSIOLOGY, 1976, 88 (01) :23-31
[3]  
BIEDLER JL, 1970, CANCER RES, V30, P1174
[4]   MECHANISM OF MULTIDRUG RESISTANCE [J].
BRADLEY, G ;
JURANKA, PF ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :87-128
[5]   ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].
DANO, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483
[6]  
FINE RL, 1988, MECHANISMS DRUG RESI, P87
[7]  
GERLACH JH, 1986, CANCER SURV, V5, P25
[8]   THE INTRACELLULAR PH OF WHITE BLOOD-CELLS - MEASUREMENT AND REGULATION [J].
GRINSTEIN, S .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1988, 66 (04) :245-249
[9]   CYTOPLASMIC PH REGULATION IN THYMIC LYMPHOCYTES BY AN AMILORIDE-SENSITIVE NA+/H+ ANTIPORT [J].
GRINSTEIN, S ;
COHEN, S ;
ROTHSTEIN, A .
JOURNAL OF GENERAL PHYSIOLOGY, 1984, 83 (03) :341-369
[10]   CROSS RESISTANCE PATTERN TOWARDS ANTICANCER DRUGS OF A HUMAN CARCINOMA MULTIDRUG-RESISTANT CELL-LINE [J].
GUPTA, RS ;
MURRAY, W ;
GUPTA, R .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :441-447